» Articles » PMID: 34108520

Clinical Predictors of Cybersickness in Virtual Reality (VR) Among Highly Stressed People

Overview
Journal Sci Rep
Specialty Science
Date 2021 Jun 10
PMID 34108520
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

The use of virtual reality (VR) in the treatment of psychiatric disorders is increasing, and cybersickness has emerged as an important obstacle to overcome. However, the clinical factors affecting cybersickness are still not well understood. In this study, we investigated clinical predictors and adaptation effect of cybersickness during VR application in highly stressed people. Eighty-three healthy adult participants with high stress level were recruited. At baseline, we conducted psychiatric, ophthalmologic, and otologic evaluations and extracted physiological parameters. We divided the participants into two groups according to the order of exposure to VR videos with different degrees of shaking and repetitively administered the Simulator Sickness Questionnaire (SSQ) and the Fast Motion sickness Scale (FMS). There was no significant difference in changes in the SSQ or the FMS between groups. The 40-59 years age group showed a greater increase in FMS compared to the 19-39 years age group. Smoking was negatively associated with cybersickness, and a high Positive Affect and Negative Affect Schedule score was positively associated with cybersickness. In conclusion, changing the intensity of shaking in VR did not affect cybersickness. While smoking was a protective factor, more expression of affect was a risk factor for cybersickness.

Citing Articles

Effectiveness and adverse effects of immersive technologies used for rehabilitation of patients with non-specific neck pain: a systematic review.

Kostka J, Zawadzka-Fabijan A, Dziala D, Bruc B, Pruszynska M, Figas G J Rehabil Med. 2025; 57:jrm42108.

PMID: 39886859 PMC: 11811534. DOI: 10.2340/jrm.v57.42108.


The Impact of Virtual Reality Content Characteristics on Cybersickness and Head Movement Patterns.

Park S, Koo D Sensors (Basel). 2025; 25(1.

PMID: 39797006 PMC: 11722776. DOI: 10.3390/s25010215.


Using iVR to deliver optimal psychotherapy experience-current perspectives on VRET for acrophobia.

Kvapil Varsova K, Jurik V Front Psychol. 2024; 15:1491622.

PMID: 39703878 PMC: 11656311. DOI: 10.3389/fpsyg.2024.1491622.


Preregistered test of whether a virtual nose reduces cybersickness.

Yip S, Ng A, Lau H, Saunders J Cogn Res Princ Implic. 2024; 9(1):74.

PMID: 39472406 PMC: 11522211. DOI: 10.1186/s41235-024-00593-3.


SAFEvR MentalVeRse.app: Development of a Free Immersive Virtual Reality Exposure Therapy for Acrophobia and Claustrophobia.

Gaina M, Sbarcea S, Popa B, Stefanescu B, Gaina A, Szalontay A Brain Sci. 2024; 14(7).

PMID: 39061393 PMC: 11274658. DOI: 10.3390/brainsci14070651.


References
1.
Li L, Yu F, Shi D, Shi J, Tian Z, Yang J . Application of virtual reality technology in clinical medicine. Am J Transl Res. 2017; 9(9):3867-3880. PMC: 5622235. View

2.
Balaban C . Vestibular nucleus projections to the parabrachial nucleus in rabbits: implications for vestibular influences on the autonomic nervous system. Exp Brain Res. 1996; 108(3):367-81. DOI: 10.1007/BF00227260. View

3.
Liu C . A neuro-fuzzy warning system for combating cybersickness in the elderly caused by the virtual environment on a TFT-LCD. Appl Ergon. 2009; 40(3):316-24. DOI: 10.1016/j.apergo.2008.12.001. View

4.
Weech S, Kenny S, Barnett-Cowan M . Presence and Cybersickness in Virtual Reality Are Negatively Related: A Review. Front Psychol. 2019; 10:158. PMC: 6369189. DOI: 10.3389/fpsyg.2019.00158. View

5.
Rothbaum B, Price M, Jovanovic T, Norrholm S, Gerardi M, Dunlop B . A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans. Am J Psychiatry. 2014; 171(6):640-8. PMC: 4115813. DOI: 10.1176/appi.ajp.2014.13121625. View